Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Promethera Biosciences
Work at Promethera Biosciences?
Add yourself to this profile
213
Promethera Biosciences
Promethera Biosciences is a biopharmaceutical company focused on cell therapyproducts to treat liver diseases.
Edit Profile
promethera.com
Technology
>
Biotechnology
Health Care
>
Medical
>
Therapeutics
B2c
Founded in
2009
Raised
$81.5M
More info
Elsewhere
Companies in the same industry
Therachon AG
Abeona Therapeutics
Seattle Genetics
Codiak Biosciences
MATINAS BIOPHARMA
Aspyrian Therapeutics
SyntheX
Tioma Therapeutics
Proclara Biosciences
Care Point Software
Alexa global traffic share
Overview
Funding
4
Add info
Latest funding
Show all
Venture capital (Series C)
€10,000,000
Mitsubishi UFJ Capital
,
Vesalius Biocapital Partners
,
Boehringer Ingelheim Venture Fund
, +4
Venture capital (Series C)
$31,444,456
Employees
Team size
10+
Locations
HQ
Belgium
Headquarters
€10,000,000
Venture capital (Series C)
businesswire
Promethera Biosciences Raises EUR 10 Million in a Series C-extension Financing to Advance its Broad Product Pipeline in Liver Diseases | Business Wire
Abeona Therapeutics
Seattle Genetics
MATINAS BIOPHARMA
Aspyrian Therapeutics
SyntheX
Care Point Software